Tessera Therapeutics
Jeffrey Berry, a Senior Scientist at Tessera Therapeutics, previously held positions as a Chemist at Nitto Avecia and Kelly. Jeffrey also worked as an ORISE Research Participant at ORAU and as a Radiochemistry Graduate Student at Washington State University. With a Ph.D. in Inorganic Chemistry from Washington State University and a Bachelor of Science in Chemistry from San Jose State University, Jeffrey has a strong background in radiochemistry and chemical method development.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.